首页 > 市场调查报告书 > 医疗设备

美容整形

市场调查报告书

商品编码

1375140

2028 年南美洲神经毒素市场预测 - COVID-19 影响和区域分析 - 按产品类型、应用和最终用户

South America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and End User

出版日期: 2023年08月24日 | 出版商:

The Insight Partners | 英文 93 Pages | 订单完成后即时交付

价格

简介目录图表

南美神经毒素市场预计将从2023年的2.8048亿美元成长到2028年的5.2557亿美元。预计2023年至2028年的复合年增长率为13.4%。

创新脸部美容产品的出现推动了南美洲神经毒素市场

预计神经毒素的整体市场将在预测期内呈指数级增长，以满足日益增长的脸部美容需求。 2022年3月，Aquavit Pharmaceuticals, Inc.宣布提交「DTX-021」的研究新药（IND），这是一种A型肉毒桿菌毒素，旨在治疗中度至重度眉间纹。本产品是一种高度纯化且经过临床测试的可注射神经调节剂，含有源自肉毒桿菌产生的神经毒素的 900 kDa 蛋白质复合物。此外，Aquavit 正在透过推出 DTX-022 加速临床试验，其最终批准将被认为是首个、也是世界上第一个全面部微注射神经毒素的产品。同样，随着减重趋势的持续，胃肉毒桿菌已成为寻求非侵入性手术的患者的热门选择。它涉及使用内视镜技术将肉毒桿菌注射到特定的胃部区域。透过这种技术，可以抑制胃部肌肉的收缩。由于这种限制，胃的排空过程需要更长的时间，这导致患者长时间感到饱腹感，导致食慾下降并改善与体重相关的健康问题/生活方式障碍，例如高血压和糖尿病。因此，创新脸部美容产品的出现有助于南美洲神经毒素市场的成长。

南美洲神经毒素市场概况

南美洲神经毒素市场分为巴西、阿根廷、委内瑞拉和南美洲其他地区。该市场的成长主要是由于越来越多地采用微创和非侵入性美容手术、老年人接受度的提高、公众对美容手术的认识不断提高、技术先进且用户友好的产品的可用性以及美容治疗的需求不断增加。由于最近的技术发展对巴西经济产生了直接影响，并在很大程度上取得了进步，因此该区域市场可能会在预测期内得到推动。在巴西，采用具有广泛适应症的微创和非侵入性美容手术（例如基于肉毒桿菌毒素的治疗）是主要的市场驱动力。巴西 A 型肉毒桿菌素製剂的品牌名称包括 Botox、Xeomin、Dysport、Botulift 和 Prosigne。此外，国际美容与整形外科医生协会 (ISAPS) 2018 年报告显示，基于肉毒桿菌毒素的治疗是巴西最常见的非手术治疗，占非手术治疗总数的 51%（约 392,530 例）。节省成本的优势和更高的工作效率被认为是製造业在南美洲建立基地的主要吸引力。

南美神经毒素市场收入及 2028 年预测（百万美元）

南美洲神经毒素市场细分

南美神经毒素市场按产品类型、应用、最终用户和国家细分。

根据产品类型，南美神经毒素市场细分为肉毒桿菌、dysport、xenomin 等。肉毒桿菌细分市场在 2023 年占据最大的市场份额。

根据应用，南美神经毒素市场分为治疗和美容市场。 2023 年，美容细分市场占据更大的市场份额。

根据最终用户，南美神经毒素市场分为医院、专科诊所、皮肤科诊所等。 2023 年，医院细分市场占据最大市场份额。

根据国家/地区，南美洲神经毒素市场分为巴西、阿根廷、委内瑞拉和南美洲其他地区。 2023 年，巴西占据市场份额主导地位。

AbbVie Inc、Hugel Inc、Ipsen SA、Meditox Inc 和 Merz Pharma GmbH & Co KGaA 是南美洲神经毒素市场的领先公司。

The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins. Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus. Therefore, emergence of innovative facial aesthetic products helps the South America neurotoxin market to grow.

South America Neurotoxins Market Overview

The South America neurotoxin market is segmented into Brazil, Argentina, Venezuela, and the Rest of South America. Growth in this market is mainly driven by the growing adoption of minimally invasive and non-invasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, availability of technologically advanced & user-friendly products, and increasing demand for aesthetic treatments. The regional market is likely to propel during the forecasted period owing to the recent technological developments that have made a direct impact on the economy of Brazil that has advanced to a large extent. In Brazil, the adoption of minimally invasive and non-invasive cosmetic procedures with a broad range of indications, such as botulinum-toxin-based treatment, are the major market drivers. The brand names of botulinum toxin A formulations available in Brazil involve Botox, Xeomin, Dysport, Botulift, and Prosigne. Additionally, the International Society of Aesthetics and Plastic Surgeons (ISAPS) 2018 report reveals that botulinum toxin-based treatment was the most common non-surgical procedure performed in Brazil, accounting for 51% (approx. 392,530) of the total non-surgical procedures. The cost savings advantage and higher work efficiencies achieved are cited as the major attracting points for manufacturing companies to establish bases in South America.

South America Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)

South America Neurotoxins Market Segmentation

The South America neurotoxins market is segmented into product type, application, end user, and country.

Based on product type, the South America neurotoxins market is subsegmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.

Based on application, the South America neurotoxins market is segmented into therapeutic and aesthetic. The aesthetic segment held a larger market share in 2023.

Based on end user, the South America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.

Based on country, the South America neurotoxins market is segmented into Brazil, Argentina, Venezuela, and the Rest of South America. Brazil dominated the market share in 2023.

AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, and Merz Pharma GmbH & Co KGaA are among the leading companies operating in the South America neurotoxins market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America neurotoxins market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South America neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South America market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South America Neurotoxin Market - by Type
- 1.3.2 South America Neurotoxin Market - by Application
- 1.3.3 South America Neurotoxin Market - by End User
- 1.3.4 South America Neurotoxin Market - by Country

2. South America Neurotoxin Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South America Neurotoxin Market - Market Landscape

4.1 Overview
4.2 South America PEST Analysis
4.3 Expert Opinion

5. South America Neurotoxin Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Surge in Cosmetic Procedures to Improve Appearance
- 5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
- 5.2.1 Improper/Inappropriate Injection Technique
5.3 Future Trends
- 5.3.1 BOTA for Assisted Reproductive Technology (ART)
5.4 Impact Analysis

6. South America Neurotoxin Market

6.1 South America Neurotoxin Market Revenue Forecast and Analysis

7. South America Neurotoxin Market - Revenue and Forecast to 2028 - By Type

7.1 Overview
7.2 South America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
- 7.3.1 Overview
- 7.3.2 Botox: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
- 7.4.1 Overview
- 7.4.2 Dysport: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
- 7.5.1 Overview
- 7.5.2 Xeomin: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

8. South America Neurotoxin Market - Revenue and Forecast to 2028 - By Application

8.1 Overview
8.2 South America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
- 8.3.1 Overview
- 8.3.2 Therapeutic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
- 8.4.1 Overview
- 8.4.2 Aesthetic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

9. South America Neurotoxin Market - Revenue and Forecast to 2028 - By End User

9.1 Overview
9.2 South America Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
- 9.4.1 Overview
- 9.4.2 Medical Spas and Beauty Centers: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
- 9.5.1 Overview
- 9.5.2 Dermatology Clinics: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

10. South America Neurotoxin Market -Revenue and Forecast to 2028- Country Analysis

10.1 Overview
- 10.1.1 South America: Neurotoxin Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 Brazil: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.1.4 Brazil: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.1.5 Brazil: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Argentina: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Argentina: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Argentina: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.3 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Venezuela: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Venezuela: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Venezuela: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.4 Rest of South America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Rest of South America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.3 Rest of South America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.4.4 Rest of South America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.4.5 Rest of South America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)

11. South America Neurotoxins Market-Industry Landscape

11.1 Overview
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Merz Pharma GmbH & Co KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Ipsen SA
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Medytox Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Hugel Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. South America Neurotoxins Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Venezuela: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Venezuela: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. Venezuela: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of South America: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of South America: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South America: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Recent Organic Growth Strategies in Neurotoxins Market
Table 15. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 16. Glossary of Terms

List Of Figures

Figure 1. South America Neurotoxin Market Segmentation
Figure 2. South America Neurotoxin Market by Country
Figure 3. South America Neurotoxin Market Overview
Figure 4. South America Neurotoxin Market, By Type
Figure 5. South America Neurotoxin Market, By Country
Figure 6. South America: PEST Analysis
Figure 7. South America Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 8. South America Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
Figure 9. South America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 10. Botox: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Dysport: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Xeomin: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. South America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 15. Therapeutic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Aesthetic: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. South America Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 18. Hospitals: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Medical Spas and Beauty Centers: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermatology Clinics: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: South America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. South America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. South America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 24. Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Rest of South America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)